Literature DB >> 30405832

Variants in the 3'-untranslated region of CUL3 is associated with risk of esophageal squamous cell carcinoma.

Jin-Long Hu1, Xin-Long Hu2, Chuang-Xin Lu1, Xue-Jiao Chen1, Lei Fu1, Qian Han3, Shun-Dong Cang1.   

Abstract

Background: Esophageal squamous cell carcinoma (ESCC) is one of the most lethal cancers in China. Recently, a study identified that cullin 3 (CUL3) was significantly mutated and deleted in ESCC. We then hypothesis that germline variants in CUL3 may also associated with the susceptibility of ESCC. Variants in the gene 3'-untranslated region (3'-UTR) may associate with gene expression by altering miRNAs binding. Material and
Methods: We systematically searched for variants in the 3'-UTR of CUL3 using the Ensembl database. Taqman SNP Genotyping Assay was performed in 638 ESCC cases and 546 controls to examine the association between the rs2396092 and the risk of ESCC. The eQTL analysis for CUL3 were conducted by using the GTEx database.
Results: We identified that the rs2396092 was significantly associated with the susceptibility of ESCC. Compared with the TT genotype carriers, the CT genotype and CC genotype carriers were correlated with risk of ESCC with odds ratio being 1.33 (95% CI: 1.04-1.70, P=0.0222) and 1.63 (95% CI: 1.07-2.50, P=0.0241), respectively. Different genotypes of rs2396092 was also shown to be correlated with altered CUL3 expression.
Conclusion: The results emphasize the importance of CUL3 in the development of ESCC and may contribute to the personalized prevention of this cancer in the future.

Entities:  

Keywords:  3'UTR; CUL3; Esophageal squamous cell carcinoma; SNP; Susceptibility

Year:  2018        PMID: 30405832      PMCID: PMC6216002          DOI: 10.7150/jca.27052

Source DB:  PubMed          Journal:  J Cancer        ISSN: 1837-9664            Impact factor:   4.207


Background

Esophageal squamous cell carcinoma (ESCC) is the fourth leading cause of cancer death in China and approximately half of the world's new ESCC cases each year occur in China 1. Epidemiology studies suggest that alcohol and tobacco consumption, nutrient deficiency and carcinogen exposure are the risk factors of this type of cancer 2. Previous genome-wide association study (GWAS) found several genetic loci that was associated with ESCC susceptibility 3-5. However, GWAS-identified variants could only explain a small fraction of the heritability 6. More functional susceptibility loci still need to be further explored. Recently, a genomic analysis identified that CUL3 was significantly mutated and deleted in ESCC 7. The cullin 3 (CUL3) was an ubiquitin ligase and was significantly correlated with cancer development, progression, and therapeutic response 8. However, the relationship between germline variation in CUL3 and ESCC susceptibility has not been investigated. MicroRNAs (miRNA) are a class of small, noncoding RNA that regulate gene expression by binding the 3'-untranslated region (3′-UTR) of mRNAs of their target genes, resulting in mRNA cleavage or translation repression 9,10. Germline variants in the 3′-UTR of miRNA target genes might alter miRNA binding and thus associated with risk of cancer by affecting gene expression 11. In the present study, we searched for variants in the 3'-UTR of CUL3 and performed a case-control study to test whether these variants are associated with ESCC susceptibility.

Materials and Methods

Study subjects

In this study, we enrolled 638 ESCC patients and 546 healthy controls. ESCC patients were enrolled from the People's Hospital of Zhengzhou University and Henan Provincial People's Hospital, Zhengzhou, China between January 1st, 2014 to November 30th, 2016. Health controls were selected from a community cancer screening program for early detection conducted in the same region during the same period as cases were collected. All participants were unrelated Han Chinese descent. The informed consent was obtained from every participant at recruitment. The demographic characteristics such as sex, age and ethnicity were obtained from the medical records. The study was approved by the Institutional Review Board of Zhengzhou University.

SNP selection and genotyping

We investigated all variants in the 3'UTR of CUL3 by using Ensembl (http://asia.ensembl.org/). There are 13 variants with global MAF > 0.05 and 6 variants with significant eQTL for CUL3 in GTex database. These 6 variants were in perfect LD with each other and the rs2396092 was selected for genotyping. The variants were genotyped by Taqman SNP Genotyping Assay (Applied Biosystems, USA).

Statistical analysis

Odds ratios (ORs) and 95% confidence intervals (CIs) adjusted for sex and age were used to assess the strength of associations between selected polymorphisms and ESCC risk by using unconditional multivariate logistic regression analysis. All statistical analyses were performed using SAS software (version 9.1; SAS Institute, Cary, NC), with a significance level of 0.05. All tests were two-sided.

Results

Characteristic of Study Subjects

The details of selected demographic characteristics including sex and age of the ESCC cases and controls were summarized in Table . The present study included 638 ESCC patients and 546 healthy controls. There are 79.9% males and 20.0% females in the cases, while there are 73.4% males and 26.6% females in controls. The average ages were 59.4 (±9.8) for cases and 63.2 (±8.2) for controls, respectively.

The rs2396092 in CUL3 was associated with the susceptibility of ESCC

The CUL3 3'-UTR variants with global minor allele frequency (MAF)>0.05 were listed (Table ). Among these variants, 6 variants were associated with CUL3 expression in GTex database and they were in perfect LD. Therefore, we selected rs2396092 as a TagSNP for genotyping. The association between rs2396092 and ESCC risk were shown in the Table . Compared with TT genotype carriers, CT genotype and CC genotype carriers were associated with risk of ESCC with OR being 1.33 (95% CI: 1.04-1.70, P=0.0222) and 1.63 (95% CI: 1.07-2.50, P=0.0241), respectively (Table ). When combing the CT genotype and CC genotype carriers, the association was more significant with P values being 0.0070 (Table ).

The rs2396092 was significantly associated with CUL3 expression

To test whether rs2396092 (tagSNP of 6 variants in the 3'-UTR of CUL3) was an expression Quantitative Trait Loci (eQTL) of CUL3, we obtained the rs3738952 data (In perfect LD with rs2396092) from the GTex database (https://gtexportal.org) 12. The CUL3 expression CC or CT genotype was significantly lower than the TT genotype with P value being in 2×10-7 in the “Muscle - Skeletal” tissue (Figure ). The rs2396092 was also significantly associated with CUL3 expression in whole blood in the Westra et al study 13.

Discussion

In this case-control study, we interrogated the association between variants in the 3'-UTR of CUL3 and ESCC susceptibility in 638 ESCC patients and 546 controls. We identified the frequency of the TC/CC genotypes of rs2396092 were significantly more than that of TT genotypes. We also found that the CUL3 expression was significantly associated with rs2396092 genotypes in two studies. The results showed that the rs2396092 T>C variant in CUL3 was correlated with the risk of ESCC and indicated that the CUL3 played an important role in the ESCC carcinogenesis. The CUL3 gene locates in chromosome 2q36.2 and encodes a member of the cullin protein family. CUL3 plays a critical role in the polyubiquitination and subsequent degradation of specific protein substrates as the core component and scaffold protein of an E3 ubiquitin ligase complex 14,15. CUL3 also plays a role in the oxidative stress response pathway and was identified to function as a tumor suppressor 16. Mutations in CUL3 have been identified to associate with multiple complex diseases, including cancer 17-20. In this study, we identified six variants in 3'-UTR of CUL3 and correlated with CUL3 expression. The genotype correlated with lower CUL3 expression was also associated with increased risk of ESCC, which is concordant with previous findings that CUL3 is an important tumor suppressor. There are some limitations for this study. First, the association still needs to be replicated in other samples. Second, the identified rs2396092 variant was only a tagSNP and further functional analysis should be conducted to identify the real functional SNP.

Conclusion

In summary, through a case-control study in a Chinese Han population, we find a significant association between CUL3 3'-UTR variants and ESCC susceptibility. These results expand our insights of ESCC carcinogenesis and provide more evidence for the precision medicine of this disease.

Funding

This work was supported by grants from Henan Provincial Science and Technique Program (162102310014) and Henan Provincial Medical Science and Technique Program (201602218).

Author contribution

Conception or design: JL Hu, SD Cang; Acquisition, analysis, or interpretation of data: JL Hu; XL Hu; CX Lu; XJ Chen; L F; Q H; Draft the manuscript: JL Hu; Review and final approval of the manuscript: All authors.
Table 1

Summary of characteristics of study subjects

Cases (n=638)Controls(n=546)
Age (years), mean±S.D.59.4±9.863.2±8.2
Gender, n (%)
Male510 (79.9)401 (73.4)
Female128 (20.0)145 (26.6)
Table 2

Genetic variants in the 3'-UTR of CUL3 with global minor allele frequency >0.05

ChrSNPPositionGeneLocationAllelesGlobal MAFGTex eQTL
2rs12470077225334971CUL33'-UTRT/C0.308-
2rs5839066225335226CUL33'-UTRA/-0.233-
2rs2396092225335290CUL33'-UTRA/G0.233CUL3
2rs4674908225335595CUL33'-UTRA/G0.453-
2rs17479770225335814CUL33'-UTRT/C0.250-
2rs3768899225336309CUL33'-UTRC/T0.233CUL3
2rs10498160225336531CUL33'-UTRC/A0.233CUL3
2rs73993899225336769CUL33'-UTRC/T0.080-
2rs3768898225336770CUL33'-UTRA/G0.233CUL3
2rs10498161225336889CUL33'-UTRT/C0.233CUL3
2rs13016316225337188CUL33'-UTRC/A0.140-
2rs3768897225338022CUL33'-UTRG/A/C0.234CUL3

Note: SNP, single nucleotide polymorphism; MAF, minor allele frequency.

Table 3

Association between rs2396092 and risk of ESCC in a Chinese population

SNPChrPositionGeneLocationGenotypeCases No. (%)Controls No. (%)OR (95% CI)aPa
rs23960922225335290CUL33'-UTRTT266 (41.7)272 (49.8)1.00 (Reference)
CT300 (47.0)232 (42.5)1.33 (1.04-1.70)0.0222
CC72 (11.3)42 (7.7)1.63 (1.07-2.50)0.0241
CT+CC372 (58.3)274 (50.2)1.38 (1.09-1.75)0.0070

aCalculated by logistic regression model adjusted for sex and age.

  20 in total

1.  Exome-wide analyses identify low-frequency variant in CYP26B1 and additional coding variants associated with esophageal squamous cell carcinoma.

Authors:  Jiang Chang; Rong Zhong; Jianbo Tian; Jiaoyuan Li; Kan Zhai; Juntao Ke; Jiao Lou; Wei Chen; Beibei Zhu; Na Shen; Yi Zhang; Ying Zhu; Yajie Gong; Yang Yang; Danyi Zou; Xiating Peng; Zhi Zhang; Xuemei Zhang; Kun Huang; Tangchun Wu; Chen Wu; Xiaoping Miao; Dongxin Lin
Journal:  Nat Genet       Date:  2018-01-29       Impact factor: 38.330

2.  Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations.

Authors:  Chen Wu; Zhibin Hu; Zhonghu He; Weihua Jia; Feng Wang; Yifeng Zhou; Zhihua Liu; Qimin Zhan; Yu Liu; Dianke Yu; Kan Zhai; Jiang Chang; Yan Qiao; Guangfu Jin; Zhe Liu; Yuanyuan Shen; Chuanhai Guo; Jianhua Fu; Xiaoping Miao; Wen Tan; Hongbing Shen; Yang Ke; Yixin Zeng; Tangchun Wu; Dongxin Lin
Journal:  Nat Genet       Date:  2011-06-05       Impact factor: 38.330

Review 3.  Genetic variation in microRNA networks: the implications for cancer research.

Authors:  Bríd M Ryan; Ana I Robles; Curtis C Harris
Journal:  Nat Rev Cancer       Date:  2010-06       Impact factor: 60.716

4.  Estimation of heritability for nine common cancers using data from genome-wide association studies in Chinese population.

Authors:  Juncheng Dai; Wei Shen; Wanqing Wen; Jiang Chang; Tongmin Wang; Haitao Chen; Guangfu Jin; Hongxia Ma; Chen Wu; Lian Li; Fengju Song; YiXin Zeng; Yue Jiang; Jiaping Chen; Cheng Wang; Meng Zhu; Wen Zhou; Jiangbo Du; Yongbing Xiang; Xiao-Ou Shu; Zhibin Hu; Weiping Zhou; Kexin Chen; Jianfeng Xu; Weihua Jia; Dongxin Lin; Wei Zheng; Hongbing Shen
Journal:  Int J Cancer       Date:  2016-10-11       Impact factor: 7.396

5.  Mutations and expression of the NFE2L2/KEAP1/CUL3 pathway in Chinese patients with lung squamous cell carcinoma.

Authors:  Yongxing Zhang; Hong Fan; Shuo Fang; Lin Wang; Li Chen; Yulin Jin; Wei Jiang; Zongwu Lin; Yu Shi; Cheng Zhan; Qun Wang
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

6.  Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions.

Authors:  Chen Wu; Peter Kraft; Kan Zhai; Jiang Chang; Zhaoming Wang; Yun Li; Zhibin Hu; Zhonghu He; Weihua Jia; Christian C Abnet; Liming Liang; Nan Hu; Xiaoping Miao; Yifeng Zhou; Zhihua Liu; Qimin Zhan; Yu Liu; Yan Qiao; Yuling Zhou; Guangfu Jin; Chuanhai Guo; Changdong Lu; Haijun Yang; Jianhua Fu; Dianke Yu; Neal D Freedman; Ti Ding; Wen Tan; Alisa M Goldstein; Tangchun Wu; Hongbing Shen; Yang Ke; Yixin Zeng; Stephen J Chanock; Philip R Taylor; Dongxin Lin
Journal:  Nat Genet       Date:  2012-09-09       Impact factor: 38.330

7.  BTB proteins are substrate-specific adaptors in an SCF-like modular ubiquitin ligase containing CUL-3.

Authors:  Lai Xu; Yue Wei; Jerome Reboul; Philippe Vaglio; Tae-Ho Shin; Marc Vidal; Stephen J Elledge; J Wade Harper
Journal:  Nature       Date:  2003-09-03       Impact factor: 49.962

8.  Cancer statistics in China, 2015.

Authors:  Wanqing Chen; Rongshou Zheng; Peter D Baade; Siwei Zhang; Hongmei Zeng; Freddie Bray; Ahmedin Jemal; Xue Qin Yu; Jie He
Journal:  CA Cancer J Clin       Date:  2016-01-25       Impact factor: 508.702

9.  Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution.

Authors:  Michal Kovac; Carolina Navas; Stuart Horswell; Max Salm; Chiara Bardella; Andrew Rowan; Mark Stares; Francesc Castro-Giner; Rosalie Fisher; Elza C de Bruin; Monika Kovacova; Maggie Gorman; Seiko Makino; Jennet Williams; Emma Jaeger; Angela Jones; Kimberley Howarth; James Larkin; Lisa Pickering; Martin Gore; David L Nicol; Steven Hazell; Gordon Stamp; Tim O'Brien; Ben Challacombe; Nik Matthews; Benjamin Phillimore; Sharmin Begum; Adam Rabinowitz; Ignacio Varela; Ashish Chandra; Catherine Horsfield; Alexander Polson; Maxine Tran; Rupesh Bhatt; Luigi Terracciano; Serenella Eppenberger-Castori; Andrew Protheroe; Eamonn Maher; Mona El Bahrawy; Stewart Fleming; Peter Ratcliffe; Karl Heinimann; Charles Swanton; Ian Tomlinson
Journal:  Nat Commun       Date:  2015-03-19       Impact factor: 14.919

10.  Systematic identification of trans eQTLs as putative drivers of known disease associations.

Authors:  Harm-Jan Westra; Marjolein J Peters; Tõnu Esko; Hanieh Yaghootkar; Claudia Schurmann; Johannes Kettunen; Mark W Christiansen; Bruce M Psaty; Samuli Ripatti; Alexander Teumer; Timothy M Frayling; Andres Metspalu; Joyce B J van Meurs; Lude Franke; Benjamin P Fairfax; Katharina Schramm; Joseph E Powell; Alexandra Zhernakova; Daria V Zhernakova; Jan H Veldink; Leonard H Van den Berg; Juha Karjalainen; Sebo Withoff; André G Uitterlinden; Albert Hofman; Fernando Rivadeneira; Peter A C 't Hoen; Eva Reinmaa; Krista Fischer; Mari Nelis; Lili Milani; David Melzer; Luigi Ferrucci; Andrew B Singleton; Dena G Hernandez; Michael A Nalls; Georg Homuth; Matthias Nauck; Dörte Radke; Uwe Völker; Markus Perola; Veikko Salomaa; Jennifer Brody; Astrid Suchy-Dicey; Sina A Gharib; Daniel A Enquobahrie; Thomas Lumley; Grant W Montgomery; Seiko Makino; Holger Prokisch; Christian Herder; Michael Roden; Harald Grallert; Thomas Meitinger; Konstantin Strauch; Yang Li; Ritsert C Jansen; Peter M Visscher; Julian C Knight
Journal:  Nat Genet       Date:  2013-09-08       Impact factor: 38.330

View more
  1 in total

1.  Genetic Variation of PD-L1 Gene Affects its Expression and Is Related to Clinical Outcome in Epithelial Ovarian Cancer.

Authors:  Haiyan Sun; Yan Li; Wengang Si; Tian Hua; Juan Chen; Shan Kang
Journal:  Front Oncol       Date:  2022-05-26       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.